Johanna Pruller, PhD

Johanna Pruller is a research associate at King’s College London where she previously obtained a PhD in molecular medicine and focused on the development of a gene therapy for alveolar rhabdomyosarcoma. She has since then studied cancer heterogeneity and its consequence on why therapies fail and how tumor cells acquire resistance mechanisms.

Articles by Johanna Pruller, PhD

3D structural model of a Cas protein and sgRNA targeting and unwinding DNA for gene editing.

CRISPR Gene Editing: Cas9 and Beyond

Abstract rendering of a tumor and its microenvironment in purple

The Basics of the Tumor Microenvironment

Page 1 of 1 - 2 Total Items
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Sex Differences in Neurological Research

Sex Differences in Neurological Research

New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio